CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg [Phase 1]
Summary
A Phase 1 study conducted to demonstrate the relative bioavailability of 1 mg alprazolam tablets (sponsored by Sandoz) for the treatment of anxiety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sandoz | Conditions: Anxiety | Phase 1 | Status: COMPLETED